Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chiara Carlotta, Pircher"'
Autor:
Sara Pusceddu, Francesca Corti, Natalie Prinzi, Federico Nichetti, Silva Ljevar, Adele Busico, Tommaso Cascella, Rita Leporati, Simone Oldani, Chiara Carlotta Pircher, Jorgelina Coppa, Veronica Resi, Massimo Milione, Marco Maccauro, Rosalba Miceli, Elena Tamborini, Federica Perrone, Carlo Spreafico, Monica Niger, Federica Morano, Filippo Pietrantonio, Ettore Seregni, Luigi Mariani, Vincenzo Mazzaferro, Giorgia Di Liberti, Giovanni Fucà, Filippo de Braud, Claudio Vernieri
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-5 (2023)
Abstract In retrospective studies, metformin use has been associated with better clinical outcomes in diabetic patients with advanced, well-differentiated neuroendocrine tumors (WDNETs). However, prospective evidence of metformin safety and activity
Externí odkaz:
https://doaj.org/article/1fcb7b069e624b61b3c438f1291779ca
Autor:
Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, Umberto Basso, Orazio Caffo, Vera Cappelletti, Melanie Claps, Ugo De Giorgi, Lucia Fratino, Valentina Guadalupi, Patrizia Miodini, Cinzia De Marco, Bruno Perrucci, Alessia Mennitto, Daniele Santini, Francesco Spina, Marco Stellato, Filippo de Braud, Elena Verzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Up to 30% of patients with metastatic castration-resistant prostate cancer (mCRPC) develop visceral metastases, which are associated with a poor prognosis. Objectives: Efficacy of enzalutamide in mCRPC patients with measurable metastases,
Externí odkaz:
https://doaj.org/article/21ea7ba220ad4b319c9536d754e3134f
Autor:
Arsela Prelaj, Edoardo Gregorio Galli, Vanja Miskovic, Mattia Pesenti, Giuseppe Viscardi, Benedetta Pedica, Laura Mazzeo, Achille Bottiglieri, Leonardo Provenzano, Andrea Spagnoletti, Roberto Marinacci, Alessandro De Toma, Claudia Proto, Roberto Ferrara, Marta Brambilla, Mario Occhipinti, Sara Manglaviti, Giulia Galli, Diego Signorelli, Claudia Giani, Teresa Beninato, Chiara Carlotta Pircher, Alessandro Rametta, Sokol Kosta, Michele Zanitti, Maria Rosa Di Mauro, Arturo Rinaldi, Settimio Di Gregorio, Martinetti Antonia, Marina Chiara Garassino, Filippo G. M. de Braud, Marcello Restelli, Giuseppe Lo Russo, Monica Ganzinelli, Francesco Trovò, Alessandra Laura Giulia Pedrocchi
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionArtificial Intelligence (AI) methods are being increasingly investigated as a means to generate predictive models applicable in the clinical practice. In this study, we developed a model to predict the efficacy of immunotherapy (IO) in pa
Externí odkaz:
https://doaj.org/article/c99b6a5fcaed44e39c58687c3976c7f5
Autor:
Giovanni, Randon, Giulia, Maddalena, Marco Maria, Germani, Chiara Carlotta, Pircher, Paolo, Manca, Francesca, Bergamo, Mirella, Giordano, Caterina, Sposetti, Aldo, Montagna, Guglielmo, Vetere, Luca, Zambelli, Cosimo, Rasola, Alessandra, Boccaccino, Filippo, Pagani, Margherita, Ambrosini, Marco, Massafra, Gabriella, Fontanini, Massimo, Milione, Matteo, Fassan, Chiara, Cremolini, Sara, Lonardi, Filippo, Pietrantonio
Publikováno v:
JCO precision oncology. 6
Several uncommon genomic alterations beyondA prospective data set at three Italian Academic Hospitals included 650 patients with mCRC with comprehensive genomic profiling by FoundationOne CDx and treated with anti-EGFRs. PRESSING2 panel alterations w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88180dcb936f4f9a6946def97c14c538
https://pubmed.ncbi.nlm.nih.gov/35849487
https://pubmed.ncbi.nlm.nih.gov/35849487
Autor:
Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Chiara Carlotta Pircher, Paolo Manca, Francesca Bergamo, Mirella Giordano, Caterina Sposetti, Aldo Montagna, Guglielmo Vetere, Luca Zambelli, Cosimo Rasola, Alessandra Boccaccino, Filippo Pagani, Margherita Ambrosini, Marco Massafra, Gabriella Fontanini, Massimo Milione, Matteo Fassan, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio
PURPOSE Several uncommon genomic alterations beyond RAS and BRAFV600E mutations drive primary resistance to anti–epidermal growth factor receptor (EGFR) monoclonal antibodies in metastatic colorectal cancer (mCRC). Our PRESSING panel (including PIK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02d2c2ee0fe60bfccc140b05153c08d
http://hdl.handle.net/11577/3451315
http://hdl.handle.net/11577/3451315
Autor:
Laura Mazzeo, Teresa Beninato, Chiara Carlotta Pircher, Marta Brambilla, Sara Manglaviti, Alessandro De Toma, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Monica Ganzinelli, Marina Chiara Garassino, Paolo Marchetti, Filippo G. De Braud, Mario Occhipinti
9057 Background: Immune checkpoint inhibitors (IO) single agent or in combination with platinum chemotherapy (CT-IO) are standard of care for Stage IV non-small cell lung cancer (NSCLC) according to PD-L1 expression. While the efficacy of IO among pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108f1c2438adbb1933b1910e5fcb11f5
http://hdl.handle.net/11573/1648220
http://hdl.handle.net/11573/1648220
Autor:
Monica Niger, Federico Nichetti, Andrea Vingiani, Chiara Carlotta Pircher, Luca Agnelli, Elena Conca, Elena Tamborini, Federica Perrone, Eleonora Gusmaroli, Andrea Franza, Francesca Corti, Leonardo Provenzano, Federica Morano, Giancarlo Pruneri, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo G. De Braud
Publikováno v:
Journal of Clinical Oncology. 41:590-590
590 Background: Biliary Tract Cancers (BTC) have poor prognosis and limited therapeutic options. There is mounting evidence for biomarker-directed therapy for BTC, with several potentially actionable molecular targets reported in up to ~50% of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26f0d68f4d5956b638b3510e639b96a8
https://doi.org/10.1200/jco.2023.41.4_suppl.590
https://doi.org/10.1200/jco.2023.41.4_suppl.590